Catarina Teixeira-Guimaraes
Porto, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Influence of RNA Modifications on Cancer Metabolism: Interplay with Hypoxia and Therapeutic Implications.
Journal: Advances in experimental medicine and biology
Published: July 11, 2026
FTO depletion does not alter m6A stoichiometry in AML mRNA: a reassessment using direct RNA nanopore sequencing.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors.
Journal: Andrology
Published: October 11, 2023
Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition.
Journal: International journal of biological sciences
Published: July 16, 2022
One sample fits all: a microfluidic-assisted methodology for label-free isolation of CTCs with downstream methylation analysis of cfDNA in lung cancer.
Journal: Biomaterials science
Published: May 18, 2022
Ki67 and LSD1 Expression in Testicular Germ Cell Tumors Is Not Associated with Patient Outcome: Investigation Using a Digital Pathology Algorithm.
Journal: Life (Basel, Switzerland)
Published: January 28, 2022
Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 17, 2021
Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor Subtypes.
Journal: Journal of personalized medicine
Published: July 27, 2021
The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 27, 2021
Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors.
Journal: Molecular oncology
Published: November 29, 2020
Last Updated: 09/26/2026